Inhibition of histone deacetylase for the treatment of biliary tract cancer: A new effective pharmacological approach

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

480

HTML

2568

Figures (1-4)

203

Tables (1-3)

140

Sum=3391

Sep 21, 2007 (publication date) through Jul 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Sep 21, 2007; 13(35): 4761-4770
Published online Sep 21, 2007. doi: 10.3748/wjg.v13.i35.4761

Table 3 MIB-1- and TUNEL-staining of mouse tumor specimens (mean, %)

Citation: Bluethner T, Niederhagen M, Caca K, Serr F, Witzigmann H, Moebius C, Mossner J, Wiedmann M. Inhibition of histone deacetylase for the treatment of biliary tract cancer: A new effective pharmacological approach. World J Gastroenterol 2007; 13(35): 4761-4770
URL: https://www.wjgnet.com/1007-9327/full/v13/i35/4761.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i35.4761